Acceptability of Zinc-fortified Lipid-based Nutrient Supplements
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of the study is to assess the acceptability of the two lipid-based nutrient supplement (LNS) formulations containing no zinc and a high amount of zinc (10 mg zinc / 20 g dose of LNS). The hypothesis is that both products will be equally accepted by children and mothers.
| Condition | Intervention | Phase |
|---|---|---|
|
Malnutrition |
Dietary Supplement: LNS with zinc Dietary Supplement: LNS without zinc |
Phase 4 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Intervention Model: Parallel Assignment Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor) Primary Purpose: Prevention |
| Official Title: | Assessment of the Acceptability of Zinc-fortified Lipid Based Nutrient (LNS) Prepared for Young Burkinabe Children |
- Amount of each type of LNS formulation consumed by young children [ Time Frame: 3 days ] [ Designated as safety issue: No ]
- Preference and detection of differences between LNS formulations among mothers [ Time Frame: 3 days ] [ Designated as safety issue: No ]
- Acceptability of feeding LNS to young children at home [ Time Frame: 2 weeks ] [ Designated as safety issue: No ]
| Enrollment: | 36 |
| Study Start Date: | July 2009 |
| Study Completion Date: | August 2009 |
| Primary Completion Date: | August 2009 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: LNS with zinc
LNS containing 10 mg zinc per 20 g dose of LNS
|
Dietary Supplement: LNS with zinc
Lipid-based nutrient supplement (LNS) containing 10 mg zinc/20 g LNS dose
Other Name: Nutriset lipid-based nutrient supplement with zinc
|
|
Placebo Comparator: LNS without zinc
LNS containing no zinc
|
Dietary Supplement: LNS without zinc
LNS containing no zinc
Other Name: Nutriset lipid-based nutrient supplement without zinc
|
Detailed Description:
We plan to conduct a series of acceptability studies to: 1) assess the amounts of zinc-free and high-zinc LNS consumed by children during direct observation, 2) compare their mothers' sensory assessments of the respective products, and 3) review maternal reports of their child feeding experiences during more prolonged home feeding trials.
Eligibility| Ages Eligible for Study: | 9 Months to 15 Months |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Currently breast-feeding and consuming complementary foods for at least 30 d
Exclusion Criteria:
- Height-for-age and weight-for height Z-scores <-3 with respect to WHO growth standards
- Edema
- Diarrhea and other diseases that could interfere with food intake
- Severe systemic illness
- History of peanut allergy
- History of anaphylaxis/serious allergic reaction
Infants meeting these criteria and their mother's will be invited to participate
Contacts and Locations| Burkina Faso | |
| Institut de Recherche en Sciences de la Santé | |
| Bobo-Dioulasso, Burkina Faso | |
| Principal Investigator: | Kenneth H. Brown, MD | University of California, Davis |
More Information
No publications provided
| Responsible Party: | Prof. Kenneth H. Brown, University of California Davis |
| ClinicalTrials.gov Identifier: | NCT00944814 History of Changes |
| Other Study ID Numbers: | 200917273, iLiNS-ACCEPT-Zinc |
| Study First Received: | July 21, 2009 |
| Last Updated: | February 18, 2010 |
| Health Authority: | Burkina Faso: Ministry of Health |
Keywords provided by University of California, Davis:
|
Lipid-based nutrient supplement Prevention of malnutrition Prevention of micronutrient deficiencies Zinc |
Additional relevant MeSH terms:
|
Malnutrition Nutrition Disorders Zinc Trace Elements |
Micronutrients Growth Substances Physiological Effects of Drugs Pharmacologic Actions |
ClinicalTrials.gov processed this record on June 17, 2013